|
1
|
Du Z, Chen J, Yan F and Xiao Y: Effects of
simvastatin on bone healing around titanium implants in
osteoporotic rats. Clin Oral Implants Res. 20:145–150. 2009.
View Article : Google Scholar
|
|
2
|
Lasota A and Danowska-Klonowska D:
Experimental osteoporosis - different methods of ovariectomy in
female white rats. Rocz Akad Med Bialymst. 49(Suppl 1): 129–131.
2004.
|
|
3
|
Reginster JY and Burlet N: Osteoporosis: a
still increasing prevalence. Bone. 38(Suppl 1): S4–S9. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shirke SS, Jadhav SR and Jagtap AG:
Methanolic extract of Cuminum cyminum inhibits ovariectomy-induced
bone loss in rats. Exp Biol Med (Maywood). 233:1403–1410. 2008.
View Article : Google Scholar
|
|
5
|
Canalis E, Giustina A and Bilezikian JP:
Mechanisms of anabolic therapies for osteoporosis. N Engl J Med.
357:905–916. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grey A and Reid IR: Emerging and potential
therapies for osteoporosis. Expert Opin Investig Drugs. 14:265–278.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lane NE and Kelman A: A review of anabolic
therapies for osteoporosis. Arthritis Res Ther. 5:214–222. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dominguez LJ, Scalisi R and Barbagallo M:
Therapeutic options in osteoporosis. Acta Biomed. 81(Suppl 1):
55–65. 2010.PubMed/NCBI
|
|
9
|
Lacey JV Jr, Mink PJ, Lubin JH, Sherman
ME, Troisi R, Hartge P, Schatzkin A and Schairer C: Menopausal
hormone replacement therapy and risk of ovarian cancer. JAMA.
288:334–341. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Reginster JY and Sarlet N: The treatment
of severe postmenopausal osteoporosis: a review of current and
emerging therapeutic options. Treat Endocrinol. 5:15–23. 2006.
View Article : Google Scholar
|
|
11
|
Rossouw JE, Anderson GL, Prentice RL,
LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA,
Howard BV, Johnson KC, Kotchen JM and Ockene J; Writing Group for
the Women’s Health Initiative Investigators: Risks and benefits of
estrogen plus progestin in healthy postmenopausal women: principal
results from the Women’s Health Initiative randomized controlled
trial. JAMA. 288:321–333. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Salari Sharif P, Abdollahi M and Larijani
B: Current, new and future treatments of osteoporosis. Rheumatol
Int. 31:289–300. 2011. View Article : Google Scholar
|
|
13
|
Putnam SE, Scutt AM, Bicknell K, Priestley
CM and Williamson EM: Natural products as alternative treatments
for metabolic bone disorders and for maintenance of bone health.
Phytother Res. 21:99–112. 2007. View
Article : Google Scholar
|
|
14
|
Cheng M, Wang Q, Fan Y, Liu X, Wang L, Xie
R, Ho CC and Sun W: A traditional Chinese herbal preparation,
Er-Zhi-Wan, prevent ovariectomy-induced osteoporosis in rats. J
Ethnopharmacol. 138:279–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen XQ, Wang QQ, Li JM, Wang YQ, Zhang XZ
and Li K: Comparison of simultaneous distillation and extraction,
static headspace and headspace-solid phase microextraction coupled
with GC/MS to measure the flavour components of Tricholoma
matsutake. Asian J Chem. 25:6059–6063. 2013.
|
|
16
|
Fan L, Ma J, Chen YH and Chen XQ:
Antioxidant and antimicrobial phenolic compounds from Setaria
viridis. Chem Nat Comp. 50:433–437. 2014. View Article : Google Scholar
|
|
17
|
Hu M, Zhao H, Dong X, Luo D and Zhou X:
General and light microscope observation on histological changes of
femoral heads between SANFH rabbit animal models and it were
intervened by Osteoking. Zhongguo Zhong Yao Za Zhi. 35:2912–2916.
2010.In Chinese.
|
|
18
|
Hu M, Zhao HB, Qian CY, Wei W, Xu HH, Tang
W, Luo DJ and Zhang Y: Ultrastructural evaluation of the SANFH
rabbit animal models intervened by Osteoking. Zhong Hua Zhong Yi
Yao Za Zhi. 26:486–489. 2011.
|
|
19
|
Zhao HB, Hu M and Liang HS: Experimental
study on osteoking in promoting gene expression of core binding
factor alpha 1 in necrotic femoral head of rabbits. Zhongguo Zhong
Xi Yi Jie He Za Zhi. 26:1003–1006. 2006.In Chinese. PubMed/NCBI
|
|
20
|
Zhao HB, Hu M, Wang WQ and Li LZ: Effects
of the VEGF gene expressions of Osteoking in the treatment of
femoral head necrosis. Zhongguo Gu Shang. 20:757–759. 2007.
|
|
21
|
Luo DJ, Zhao HB, Dong XL, Li LZ, Wang WZ
and Xiong H: The study on treatment of vertebral ostoporotic
fracture by salmon calcitonin and Heng Gu bong healing reagent.
Chin J Endocr Surg. 5:158–160. 2011.
|
|
22
|
Zhao HB, Wang B, Zhao XL, Li LZ, Li SH, Li
YG, Chen ZY and Luo XR: Osteoking in the treatment of ischemic
necrosis of femoral head: long-term results in 76 patients. Chin J
Pract Chin Modern Med. 4:2906–2907. 2004.
|
|
23
|
Zhao HB, Hu M, Zheng HY, Liang HS and Zhu
XS: Clinical study on effect of Osteoking in preventing
postoperational deep venous thrombosis in patients with
intertrochanteric fracture. Chin J Integr Med. 11:297–299. 2005.
View Article : Google Scholar
|
|
24
|
Castañeda S, Largo R, Calvo E,
Rodríguez-Salvanés F, Marcos ME, Díaz-Curiel M and Herrero-Beaumont
G: Bone mineral measurements of subchondral and trabecular bone in
healthy and osteoporotic rabbits. Skeletal Radiol. 35:34–41. 2006.
View Article : Google Scholar
|
|
25
|
Liu X, Lei W, Wu Z, Cui Y, Han B, Fu S and
Jiang C: Effects of glucocorticoid on BMD, micro-architecture and
biomechanics of cancellous and cortical bone mass in OVX rabbits.
Med Eng Phys. 34:2–8. 2012. View Article : Google Scholar
|
|
26
|
Cao DP, Zheng YN, Qin LP, Han T, Zhang H,
Rahman K and Zhang QY: Curculigo orchioides, a traditional Chinese
medicinal plant, prevents bone loss in ovariectomized rats.
Maturitas. 59:373–380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nian H, Qin LP, Zhang QY, Zheng HC, Yu Y
and Huang BK: Antiosteoporotic activity of Er-Xian Decoction, a
traditional Chinese herbal formula, in ovariectomized rats. J
Ethnopharmacol. 108:96–102. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Baofeng L, Zhi Y, Bei C, Guolin M,
Qingshui Y and Jian L: Characterization of a rabbit osteoporosis
model induced by ovariectomy and glucocorticoid. Acta Orthop.
81:396–401. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schorlemmer S, Ignatius A, Claes L and
Augat P: Inhibition of cortical and cancellous bone formation in
glucocorticoid-treated OVX sheep. Bone. 37:491–496. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Akhter MP, Cullen DM, Gong G and Recker
RR: Bone biome-chanical properties in prostaglandin EP1 and EP2
knockout mice. Bone. 29:121–125. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Scholz-Ahrens KE, Delling G, Stampa B,
Helfenstein A, Hahne HJ, Acil Y, Timm W, Barkmann R, Hassenpflug J,
Schrezenmeir J and Glüer CC: Glucocorticosteroid-induced
osteoporosis in adult primiparous Göttingen miniature pigs: effects
on bone mineral and mineral metabolism. Am J Physiol Endocrinol
Metab. 293:E385–395. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Arens AM, Barr B, Puchalski SM, Poppenga
R, Kulin RM, Anderson J and Stover SM: Osteoporosis associated with
pulmonary silicosis in an equine bone fragility syndrome. Vet
Pathol. 48:593–615. 2011. View Article : Google Scholar
|
|
33
|
Zhang Y, Yu L, Ao M and Jin W: Effect of
ethanol extract of Lepidium meyenii Walp. on osteoporosis in
ovariectomized rat. J Ethnopharmacol. 105:274–279. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen H, Wu M and Kubo KY: Combined
treatment with a traditional Chinese medicine, Hachimi-jio-gan
(Ba-Wei-Di-Huang-Wan) and alendronate improves bone micro-structure
in ovariectomized rats. J Ethnopharmacol. 142:80–85. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hordon LD, Itoda M, Shore PA, Shore RC,
Heald M, Brown M, Kanis JA, Rodan GA and Aaron JE: Preservation of
thoracic spine microarchitecture by alendronate: comparison of
histology and microCT. Bone. 38:444–449. 2006. View Article : Google Scholar
|
|
36
|
Zhao FD, Pollintine P, Hole BD, Adams MA
and Dolan P: Vertebral fractures usually affect the cranial
endplate because it is thinner and supported by less-dense
trabecular bone. Bone. 44:372–379. 2009. View Article : Google Scholar
|
|
37
|
Castañeda S, Calvo E, Largo R,
González-González R, de la Piedra C, Díaz-Curiel M and
Herrero-Beaumont G: Characterization of a new experimental model of
osteoporosis in rabbits. J Bone Miner Metab. 26:53–59. 2008.
View Article : Google Scholar
|
|
38
|
Bellido M, Lugo L, Castañeda S, Roman-Blas
JA, Rufián-Henares JA, Navarro-Alarcón M, Largo R and
Herrero-Beaumont G: PTH increases jaw mineral density in a rabbit
model of osteoporosis. J Dent Res. 89:360–365. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mosekilde L: Assessing bone quality-animal
models in preclinical osteoporosis research. Bone. 17(Suppl):
343S–352S. 1995. View Article : Google Scholar
|
|
40
|
Rodgers JB, Monier-Faugere MC and Malluche
H: Animal models for the study of bone loss after cessation of
ovarian function. Bone. 14:369–377. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Turner AS: Animal models of osteoporosis -
necessity and limitations. Eur Cells Mater. 1:66–81. 2001.
|
|
42
|
Cao T, Shirota T, Ohno K and Michi KI:
Mineralized bone loss in partially edentulous trabeculae of
ovariectomized rabbit mandibles. J Periodontal Res. 39:37–41. 2004.
View Article : Google Scholar
|
|
43
|
Cao T, Shirota T, Yamazaki M, Ohno K and
Michi KI: Bone mineral density in mandibles of ovariectomized
rabbits. Clin Oral Implants Res. 12:604–608. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chaki O, Yoshikata I, Kikuchi R, Nakayama
M, Uchiyama Y, Hirahara F and Gorai I: The predictive value of
biochemical markers of bone turnover for bone mineral density in
postmenopausal Japanese women. J Bone Miner Res. 15:1537–1544.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Eastell R, Colwell A, Hampton L and Reeve
J: Biochemical markers of bone resorption compared with estimates
of bone resorption from radiotracer kinetic studies in
osteoporosis. J Bone Miner Res. 12:59–65. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Garnero P, Sornay-Rendu E, Duboeuf F and
Delmas PD: Markers of bone turnover predict postmenopausal forearm
bone loss over 4 years: the OFELY study. J Bone Miner Res.
14:1614–1621. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Whitaker M, Guo J, Kehoe T and Benson G:
Bisphosphonates for osteoporosis - where do we go from here? N Engl
J Med. 366:2048–2051. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Delmas PD, Eastell R, Garnero P, Seibel MJ
and Stepan J; Committee of Scientific Advisors of the International
Osteoporosis Foundation: The use of biochemical markers of bone
turnover in osteoporosis. Committee of Scientific Advisors of the
International Osteoporosis Foundation. Osteoporosis Int. 11(Suppl
6): S2–S17. 2000. View Article : Google Scholar
|
|
49
|
Garnero P, Sornay-Rendu E, Chapuy MC and
Delmas PD: Increased bone turnover in late postmenopausal women is
a major determinant of osteoporosis. J Bone Miner Res. 11:337–349.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Szulc P and Delmas PD: Biochemical markers
of bone turnover: potential use in the investigation and management
of postmenopausal osteoporosis. Osteoporos Int. 19:1683–1704. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Armamento-Villareal R, Napoli N, Panwar V
and Novack D: Suppressed bone turnover during alendronate therapy
for high-turnover osteoporosis. N Engl J Med. 355:2048–2050. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Turner CH: Biomechanics of bone:
determinants of skeletal fragility and bone quality. Osteoporos
Int. 13:97–104. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Bouxsein Ml: Determinants of skeletal
fragility. Best Pract Res Clin Rheumatol. 19:897–911. 2005.
View Article : Google Scholar : PubMed/NCBI
|
